Alkermes has reached an agreement to buy Avadel Pharma in a deal valued at up to $2.1 billion, claiming rights to an ...

While the study only involved narcolepsy type 1, previous work has shown that orexin signaling may be deficient in other ...

Detailed price information for Harmony Biosciences Holdings Inc (HRMY-Q) from The Globe and Mail including charting and trades.

Later, I learned that circadian rhythm disorders are very common in bipolar disorder. The condition disrupts the body’s sleep ...

A new study has lifted the lid on what it feels like to live with chronic tiredness which no amount of sleep can shift.

CHRISTUS Health in Shreveport has opened a new state-of-the-art sleep lab to support early detection and treatment of ...

Alkermes acquires Avadel for $2.1 billion, enhancing its sleep medicine market presence and commercial portfolio with Lumryz. The acquisition supports Alkermes' development pipeline for central ...

Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, today announced the global settlement of all litigation with Jazz ...

Alkermes plc (Nasdaq: ALKS) ("Alkermes") and Avadel Pharmaceuticals plc (Nasdaq: AVDL) ("Avadel") today announced that the companies have entered into a definitive agreement under which Alkermes will ...

An oversubscribed seed funding round will give Procyon the financial resources it needs to launch its first diagnostic – ...

The recreations in The Nightmare aren’t just moody filler—they're legit horror sequences. Ascher shoots them with the same ...